67 related articles for article (PubMed ID: 27698935)
1. Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma.
Alafate W; Lv G; Zheng J; Cai H; Wu W; Yang Y; Du S; Zhou D; Wang P
Cell Death Dis; 2024 May; 15(5):366. PubMed ID: 38806469
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of tumor-immune symbiosis in glioma.
Liu Y; Ali H; Khan F; Pang L; Chen P
Trends Mol Med; 2024 May; 30(5):429-442. PubMed ID: 38453529
[TBL] [Abstract][Full Text] [Related]
3. The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets.
Ren J; Xu B; Ren J; Liu Z; Cai L; Zhang X; Wang W; Li S; Jin L; Ding L
Brain Sci; 2023 Aug; 13(9):. PubMed ID: 37759870
[TBL] [Abstract][Full Text] [Related]
4. Misregulation of the expression and activity of DNA methyltransferases in cancer.
Mensah IK; Norvil AB; AlAbdi L; McGovern S; Petell CJ; He M; Gowher H
NAR Cancer; 2021 Dec; 3(4):zcab045. PubMed ID: 34870206
[TBL] [Abstract][Full Text] [Related]
5. A Rare Manifestation of a Presumed Non-Osteophilic Brain Neoplasm: Extensive Axial Skeletal Metastases From Glioblastoma With Primitive Neuronal Components.
Rong T; Zou W; Qiu X; Cui W; Zhang D; Wu B; Kang Z; Li W; Liu B
Front Oncol; 2021; 11():760697. PubMed ID: 34796114
[TBL] [Abstract][Full Text] [Related]
6. Activation of JNK and p38 MAPK Mediated by ZDHHC17 Drives Glioblastoma Multiforme Development and Malignant Progression.
Chen X; Hao A; Li X; Ye K; Zhao C; Yang H; Ma H; Hu L; Zhao Z; Hu L; Ye F; Sun Q; Zhang H; Wang H; Yao X; Fang Z
Theranostics; 2020; 10(3):998-1015. PubMed ID: 31938047
[No Abstract] [Full Text] [Related]
7. miR-370-3p Is a Therapeutic Tool in Anti-glioblastoma Therapy but Is Not an Intratumoral or Cell-free Circulating Biomarker.
Nadaradjane A; Briand J; Bougras-Cartron G; Disdero V; Vallette FM; Frenel JS; Cartron PF
Mol Ther Nucleic Acids; 2018 Dec; 13():642-650. PubMed ID: 30497054
[TBL] [Abstract][Full Text] [Related]
8. Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma.
Hervouet E; Peixoto P; Delage-Mourroux R; Boyer-Guittaut M; Cartron PF
Clin Epigenetics; 2018; 10():17. PubMed ID: 29449903
[TBL] [Abstract][Full Text] [Related]
9. Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.
Zarnett OJ; Sahgal A; Gosio J; Perry J; Berger MS; Chang S; Das S
JAMA Neurol; 2015 May; 72(5):589-96. PubMed ID: 25822375
[TBL] [Abstract][Full Text] [Related]
10. Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial.
Mason WP; Cairncross JG
Nat Clin Pract Neurol; 2005 Dec; 1(2):88-95. PubMed ID: 16932504
[TBL] [Abstract][Full Text] [Related]
11. Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth.
Cheray M; Pacaud R; Nadaradjane A; Oliver L; Vallette FM; Cartron PF
Theranostics; 2016; 6(11):1988-1999. PubMed ID: 27698935
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness.
Cheray M; Nadaradjane A; Bonnet P; Routier S; Vallette FM; Cartron PF
Epigenomics; 2014 Jun; 6(3):267-75. PubMed ID: 25111481
[TBL] [Abstract][Full Text] [Related]
13. Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts.
Lefranc F; James S; Camby I; Gaussin JF; Darro F; Brotchi J; Gabius J; Kiss R
J Neurosurg; 2005 Apr; 102(4):706-14. PubMed ID: 15871514
[TBL] [Abstract][Full Text] [Related]
14. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
Brandes AA; Franceschi E; Tosoni A; Benevento F; Scopece L; Mazzocchi V; Bacci A; Agati R; Calbucci F; Ermani M
Cancer; 2009 Aug; 115(15):3512-8. PubMed ID: 19514084
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
